Laboratory News and Research

RSS

Findings demonstrate that abnormal expression of the BCL6 gene causes lymphoma

This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin’s lymphomas, the sixth leading cause of cancer deaths in the United States.

23 May 2005

LeTourneau University engineering students aid disabled Kenyans

Senior engineering students from LeTourneau University are leaving for Kijabe, Kenya, to fit disabled Kenyan children with free prosthetics.

23 May 2005

Russian team tests new polymeric coating for vascular stents

A group of researchers of the Institute of Biophysics (Russian Academy of Sciences), Krasnoyarsk regional clinical hospital and Krasnoyarsk regional department of morbid anatomy under the guidance of .I. Gitelzon, Academician of Russian Academy of Sciences, have tested characteristics of a new polymeric coating for vascular stents.

22 May 2005

WHO says world must prepare for bird flu pandemic

Reports of disturbing changes to the H5N1 virus circulating in Asia is causing great concern and has prompted the World Health Organization (WHO) to urge countries to prepare for a influenza pandemic.

22 May 2005

Discovery may lead to new drugs to treat cancer, control fertility

A recent discovery in cellular biology may allow scientists to enhance organ regeneration by stem cells, prevent the progression of cancer, and control fertility.

22 May 2005

Researchers generate patient-specific stem cells

Researchers have isolated the first human embryonic stem cell lines specifically tailored to match the nuclear DNA of patients, both males and females of various ages, suffering from disease or spinal cord injury.

20 May 2005

FDA recommends approval of the investigational anti-HIV drug tipranavir

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee recommended the approval of the investigational anti-HIV drug tipranavir (11-3). Tipranavir is a non-peptidic protease inhibitor that requires boosting with low-dose ritonavir and must be used in combination with other antiretroviral agents.

20 May 2005

Study holds implications for gene therapy and stem cell biology

The study, conducted by scientists from Cincinnati Children's Hospital Medical Center, and Hannover Medical School and Hamburg University in Germany, reveals important evidence that tells us more about how blood forming stem cells regenerate. On the other hand, scientists offer caution in regards to the side effects associated with genetic engineering of stem cells.

20 May 2005

Nurture as important as nature in developing ability for flexible self-control

Your ability to follow the rules of the road when driving on unfamiliar streets exists thanks to the way your pre-teen life experiences influenced the development of your brain. Individuals deprived of normal life experiences may lack this ability to control their behavior in novel situations, a new computer model suggests, providing insight into how nature and nurture may interact in the development of self-control.

20 May 2005

UN wants ban on creation of smallpox virus in labs

Health officials around the world are being urged by United Nations experts to ban scientists from making the deadly smallpox virus in laboratories for fear it could fall into terrorist hands.

18 May 2005

EraGen Biosciences and Bayer announce agreements for new cystic fibrosis (CF) assay

EraGen Biosciences, a rapidly growing molecular diagnostics company and Bayer HealthCare LLC, Diagnostics Division, announced today that EraGen has licensed its patented MultiCode-PLx® System to Bayer HealthCare in an exclusive worldwide agreement for Cystic Fibrosis.

18 May 2005

Global project to combat parasites that cause cancer and infection in millions

Many cancers are associated with infections (for example cervical cancer is linked to the human papilloma virus) but there is no stronger link between a human malignancy and a parasitic infection than that between cancer of the bile ducts and a liver fluke called Opisthorchis viverrini.

18 May 2005

New combination vaccine effective against plague

Plague, a bacterium that ravaged Europe in the Middle Ages and is today one of the most feared potential agents of bio-terrorism, may have met its match, according to Wake Forest University School of Medicine scientists.

18 May 2005

Researchers prevent post-traumatic brain damage using experimental drug

In animal studies, researchers from Georgetown University Medical Center have shown how traumatic brain injury leads to loss of brain function - and found that an experimental drug can stop the damage and promote recovery.

18 May 2005

Testosterone appears to benefit, not harm, cardiovascular health of middle-aged men

Although men suffer more coronary heart disease than women, the blame should not be placed on testosterone, according to a new study in the May 17, 2005, issue of the Journal of the American College of Cardiology.

18 May 2005

Unrestrained retina too much of a good thing

When primitive nerve cells begin forming an eye in the mouse embryo, they are programmed to build a retina. But the ability to see depends upon connecting the retina to the brain via the optic nerve. Unless these embryonic cells are given the right cue at the right time, they mistakenly form a huge eye that consists entirely of retina and lacks the optic nerve.

18 May 2005

Chronic stress can be harmful - to your health and also to your brain

Chronic stress can be harmful - to your health and also to your brain, according to researchers at the Douglas Hospital Research Center. Their findings, published in a recent issue of Psychoneuroendocrinology, show increased stress hormones lead to memory impairment in the elderly and learning difficulties in young adults.

17 May 2005

Patients who have a blood clot are at high risk of having another one, and men have more than twice the risk as women

While estimates of the overall risk of a thrombotic (blood clot) event recurrence vary, reports on contributing factors are contradictory, according to background information in the article. Knowledge of the risk of a thrombotic event recurrence and its determinants is relevant for clinical policy regarding screening for thrombophilia (increased risk for blood clot), duration of anticoagulant treatment, and treatment strategies in circumstances of increased risk.

17 May 2005

Tumor vasculature has become an attractive target in the treatment of cancer.

Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.

17 May 2005